Drug recall

Platelets Pheresis, Leukocytes Reduced

FDA recall event 27028 · Class II · The Blood Center Of New Jersey

Key facts

Event ID 27028
Recall numbers B-1795-3
Recalling firm The Blood Center Of New Jersey
Product type Biologics
Products Platelets Pheresis, Leukocytes Reduced
Classification Class II
Status Completed
Voluntary or mandated Firm Initiated
Reason for recall Blood products, that were labeled leukoreduced but were not tested to determine the white blood cell count as required in the firm's standard operating procedures, were distributed.
Initiation date Apr 8, 2002
City East Orange
Country United States
FEI number 2270831

At a glance

  • 1–9 Products in this recall
  • 10–99 FDA inspections of this firm (FEI)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA drug and product recalls

FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.

Source: U.S. Food and Drug Administration (FDA), Enforcement Reports

Browse all FDA drug and product recalls